1
Clinical Trials associated with Umbilical cord mesenchymal stem cells(Cellonis Biotechnology)A Pilot Study on Transplantation Therapy Using Autologous Bone Marrow Mononuclear Cells and Umbilical Cord Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus
The purpose of this study is to evaluate the feasibility, efficacy and safety of transplantation therapy using bone marrow mononuclear cells and umbilical cord mesenchymal stem cells for patients with type 1 diabetes mellitus
100 Clinical Results associated with Umbilical cord mesenchymal stem cells(Cellonis Biotechnology)
100 Translational Medicine associated with Umbilical cord mesenchymal stem cells(Cellonis Biotechnology)
100 Patents (Medical) associated with Umbilical cord mesenchymal stem cells(Cellonis Biotechnology)
100 Deals associated with Umbilical cord mesenchymal stem cells(Cellonis Biotechnology)